These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11839452)

  • 1. Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers.
    Sánchez-Lafuente C; Teresa Faucci M; Fernández-Arévalo M; Alvarez-Fuentes J; Rabasco AM; Mura P
    Int J Pharm; 2002 Mar; 234(1-2):213-21. PubMed ID: 11839452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eudragit RS-PM and Ethocel 100 Premium: influence over the behavior of didanosine inert matrix system.
    Sánchez-Lafuente C; Rabasco AM; Alvarez-Fuentes J; Fernández-Arévalo M
    Farmaco; 2002 Aug; 57(8):649-56. PubMed ID: 12361232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design.
    Sánchez-Lafuente C; Furlanetto S; Fernández-Arévalo M; Alvarez-Fuentes J; Rabasco AM; Faucci MT; Pinzauti S; Mura P
    Int J Pharm; 2002 Apr; 237(1-2):107-18. PubMed ID: 11955809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral sustained-release bioadhesive tablet formulation of didanosine.
    Betageri GV; Deshmukh DV; Gupta RB
    Drug Dev Ind Pharm; 2001 Feb; 27(2):129-36. PubMed ID: 11266224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.
    Khan KA; Khan GM; Zeeshan Danish M; Akhlaq ; Khan H; Rehman F; Mehsud S
    Int J Pharm; 2015 Dec; 496(2):759-65. PubMed ID: 26545310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells.
    Santos JV; Pina ME; Marques MP; de Carvalho LA
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1154-66. PubMed ID: 22439754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide.
    Takka S; Singh Bharaj S; Sakr A
    Pharmazie; 2003 Dec; 58(12):886-90. PubMed ID: 14703967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.
    Kuksal A; Tiwary AK; Jain NK; Jain S
    AAPS PharmSciTech; 2006 Jan; 7(1):E1. PubMed ID: 16584139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline.
    Afrasiabi Garekani H; Faghihnia Torshizi M; Sadeghi F
    Drug Dev Ind Pharm; 2015; 41(10):1655-60. PubMed ID: 25402967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU
    Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
    Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.